Status:
COMPLETED
Iranian Intensive Care Unit (ICU) Glutamine Study
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Collaborating Sponsors:
Isfahan University of Medical Sciences
Conditions:
Trauma Patients in ICU
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This is a double-blinded placebo-controlled block randomized study in intensive care patients comparing enteral glutamine supplementation to placebo. The hypothesis is an improvement of clinical and p...
Eligibility Criteria
Inclusion
- Age 18-60
- No corticosteroids use
- No history of heart, liver and kidney diseases
- Nutrition through nasogastric or orogastric
Exclusion
- Patients who will not tolerate enteral nutrition for more than 48 hours
- Patients who are NPO and nutritional support has not started
- Lactating and pregnant women
- Kidney failure during the study
- A history of glutamin supplement use before the study
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01219608
Start Date
January 1 2010
End Date
June 1 2011
Last Update
June 14 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Zahra Hospital
Isfahan, Isfahan, Iran